Spectrum of practice in the routine management of cervical dystonia with abobotulinumtoxinA: findings from three prospective open-label observational studies.

Journal of Clinical Movement Disorders Pub Date : 2018-07-09 eCollection Date: 2018-01-01 DOI:10.1186/s40734-018-0072-8
Vijay P Misra, Richard M Trosch, Pascal Maisonobe, Savary Om
{"title":"Spectrum of practice in the routine management of cervical dystonia with abobotulinumtoxinA: findings from three prospective open-label observational studies.","authors":"Vijay P Misra,&nbsp;Richard M Trosch,&nbsp;Pascal Maisonobe,&nbsp;Savary Om","doi":"10.1186/s40734-018-0072-8","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Cervical dystonia is a heterogeneous disorder with several possible presentations, for which first-line therapy is often botulinum toxin (BoNT). In routine clinical practice the success of each BoNT injection is dependent on several variables, including individual presentation and injection technique. Large multicenter, observational studies provide important information on individualized administration strategies that cannot be otherwise ascertained from controlled clinical trials. In this meta-analysis of patient level data, we aimed to evaluate the clinical characteristics of patients with cervical dystonia undergoing routine treatment with botulinum toxin, specifically abobotulinumtoxinA. We also aimed to characterize current abobotulinumtoxinA injection techniques and parameters and to explore international differences in patient presentation and treatment.</p><p><strong>Methods: </strong>This was a meta-analysis of baseline data from three prospective, international, multicenter, observational studies (NCT01314365, NCT00833196 and NCT01753349) of botulinum toxin treatment for the routine management of adult cervical dystonia.</p><p><strong>Results: </strong>Data presented illustrate the significant heterogeneity of CD presentation in routine practice. Most subjects presented with a complex pattern of dystonic movements and the majority had additional components of shoulder elevation, tremor and/or jerk. Dosing was generally in accordance with that recommended in the abobotulinumtoxinA prescribing information, although the range of dosing also indicates that injections are tailored to individual presentation. Sub-group analyses at the country level revealed distinct differences in injection practice.</p><p><strong>Conclusions: </strong>This meta-analysis is based on the largest dataset of subjects with cervical dystonia studied to date. The heterogeneity revealed in our baseline findings support the need to develop consistent, practical and comprehensive best practice guidelines.</p>","PeriodicalId":15374,"journal":{"name":"Journal of Clinical Movement Disorders","volume":"5 ","pages":"4"},"PeriodicalIF":0.0000,"publicationDate":"2018-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s40734-018-0072-8","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Movement Disorders","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s40734-018-0072-8","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2018/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 5

Abstract

Background: Cervical dystonia is a heterogeneous disorder with several possible presentations, for which first-line therapy is often botulinum toxin (BoNT). In routine clinical practice the success of each BoNT injection is dependent on several variables, including individual presentation and injection technique. Large multicenter, observational studies provide important information on individualized administration strategies that cannot be otherwise ascertained from controlled clinical trials. In this meta-analysis of patient level data, we aimed to evaluate the clinical characteristics of patients with cervical dystonia undergoing routine treatment with botulinum toxin, specifically abobotulinumtoxinA. We also aimed to characterize current abobotulinumtoxinA injection techniques and parameters and to explore international differences in patient presentation and treatment.

Methods: This was a meta-analysis of baseline data from three prospective, international, multicenter, observational studies (NCT01314365, NCT00833196 and NCT01753349) of botulinum toxin treatment for the routine management of adult cervical dystonia.

Results: Data presented illustrate the significant heterogeneity of CD presentation in routine practice. Most subjects presented with a complex pattern of dystonic movements and the majority had additional components of shoulder elevation, tremor and/or jerk. Dosing was generally in accordance with that recommended in the abobotulinumtoxinA prescribing information, although the range of dosing also indicates that injections are tailored to individual presentation. Sub-group analyses at the country level revealed distinct differences in injection practice.

Conclusions: This meta-analysis is based on the largest dataset of subjects with cervical dystonia studied to date. The heterogeneity revealed in our baseline findings support the need to develop consistent, practical and comprehensive best practice guidelines.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
肉毒杆菌毒素对宫颈肌张力障碍的常规治疗:来自三个前瞻性开放标签观察性研究的结果。
背景:宫颈肌张力障碍是一种异质性疾病,有多种可能的表现,其一线治疗通常是肉毒杆菌毒素(BoNT)。在常规临床实践中,每次BoNT注射的成功取决于几个变量,包括个人表现和注射技术。大型多中心观察性研究提供了无法通过对照临床试验确定的个体化给药策略的重要信息。在这项患者水平数据的荟萃分析中,我们旨在评估接受肉毒杆菌毒素(特别是肉毒杆菌毒素)常规治疗的宫颈肌张力障碍患者的临床特征。我们还旨在描述目前的肉毒杆菌毒素注射技术和参数,并探讨患者表现和治疗的国际差异。方法:本研究对3项前瞻性、国际、多中心、观察性研究(NCT01314365、NCT00833196和NCT01753349)的基线数据进行荟萃分析,研究内容是肉毒杆菌毒素治疗成人宫颈肌张力障碍的常规治疗。结果:所提供的数据说明了常规实践中CD表现的显著异质性。大多数患者表现为复杂的肌张力障碍运动模式,大多数患者伴有肩抬高、震颤和/或抽搐等附加症状。剂量一般按照肉毒杆菌毒素处方信息中推荐的剂量,尽管剂量范围也表明注射是根据个人情况量身定制的。国家一级的分组分析显示,注射实践存在明显差异。结论:本荟萃分析是基于迄今为止研究的最大的颈椎肌张力障碍受试者数据集。我们的基线研究结果显示的异质性支持了制定一致、实用和全面的最佳实践指南的必要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Continuous subcutaneous apomorphine infusion allowing awake deep brain stimulation in a Parkinson's disease patient. Video-based long-term follow up of musician’s dystonia in pianists reveals similar improvements following different treatment strategies: a retrospective observational study AbobotulinumtoxinA using 2-mL dilution (500 U/2-mL) maintains durable improvement across multiple treatment cycles. Potential impact and challenges associated with Parkinson's disease patient care amidst the COVID-19 global pandemic. Correction to: Economic evaluation of AbobotulinumtoxinA vs OnabotulinumtoxinA in real-life clinical management of cervical dystonia.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1